Article
Proving equivalence of originator and an authorized generic drug following EMA draft guideline on quality and equivalence of topical products
2024-06-06
Abstract excerpt
<h4>Aim: </h4> Today, the approval for a generic topical product includes the presentation of therapeutic equivalence to the originator based on clinical trials. To facilitate this procedure, in 2018 the European Medicines Agency (EMA) published a draft guideline on quality and equivalence of topical products, which includes request parameters regarding the quality of the newly developed generic product and test p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7bc97c0-16fb-5afd-9876-5f77a50f05a7
- DOI
- 10.22541/au.171600574.43353285/v2
